Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Agency: National Institutes of Health
- 93.394 -- Cancer Detection and Diagnosis Research
Forecasted opportunityLast Updated: Jul 14, 2026
Important dates
- Forecasted post date: January 15, 2027
- Forecasted application due date: June 4, 2027
- Forecasted award date: April 1, 2028
- Forecasted project start date: April 15, 2028
- Fiscal Year: 2028
Award details
- Expected project funding: $5,400,000
- Expected awards: 23
Award min.
Not specified
Award max.
$150,000
- Funding opportunity number:RFA-CA-28-001
- Cost sharing or matching requirement:No
- Funding instrument type:
- Grant
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Forecast posted date: July 14, 2026
- Archive date: Not specified
- Version: 1
Summary
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies for cancer research or clinical care. The emphasis of this NOFO is on early-stage projects proposing proof-of-concept/pilot studies to test the technical feasibility of the proposed method, tool, assay, platform, or instrument.
Well-suited applications must offer a high degree of technical innovation and the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, cancer control, and/or epidemiology. Projects that are in-scope include technologies with new or significantly improved technical capabilities to measure, analyze, model, or interrogate cancer-related systems. These may include, but are not limited to, advanced molecular and cellular analysis platforms, multi-omic and spatial profiling methods, imaging and sensing technologies, immuno-engineering approaches, and innovations in biospecimen processing, modeling, and quality assessment. Technologies proposed for development may have potential for widespread applicability but must be focused in this proposal on cancer applications.
This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
Eligibility
Business
- For-profit organizations other than small businesses
- Small businesses
Miscellaneous
- Other
Government
- City or township governments
- Federally recognized Native American tribal governments
- County governments
- State governments
- Special district governments
- Public and Indian housing authorities
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Additional information on eligibility
Documents
No documents are currently available.
Link to additional information
No additional information is available
